Zobrazeno 1 - 10
of 12 567
pro vyhledávání: '"intestinal metaplasia"'
Autor:
A. V. Kononov, V. A. Rubtsov, M. N. Parygina, A. G. Shimanskaya, S. I. Mozgovoi, E. G. Pomorgailo, M. V. Markelova, Yu. A. Fedotova
Publikováno v:
Российский журнал гастроэнтерологии, гепатологии, колопроктологии, Vol 34, Iss 4, Pp 50-63 (2024)
Aim: to evaluate the possibility of the MMR-system status, microsatellite instability (MSI) usage in the differential diagnosis of gastric mucosa dysplasia, determination of the gastric adenocarcinoma development risk. Material and methods. The study
Externí odkaz:
https://doaj.org/article/8bb79f1520814db4af9ebe15e23581b6
Autor:
Tai Zhang, Xudong Tang
Publikováno v:
Molecular Cancer, Vol 23, Iss 1, Pp 1-6 (2024)
Abstract This commentary offers a thoughtful discussion of the study by Wei et al. published in the journal on the role of Olfactomedin 4 (OLFM4) in incomplete intestinal metaplasia, a gastric precancerous condition. The original paper introduces OLF
Externí odkaz:
https://doaj.org/article/de49d468a77046b8ae77000ff4067e4f
Publikováno v:
Zhongguo quanke yixue, Vol 27, Iss 20, Pp 2466-2475 (2024)
Background Chronic atrophic gastritis (CAG) with intestinal metaplasia (IM) is an independent risk factor for gastric cancer. Long-term inflammation and oxidative stress response stimulate the physical and mental state of patients. Under the modern m
Externí odkaz:
https://doaj.org/article/c03bd2a0f7d747e0bfe32a04a7e37a8c
Publikováno v:
Archives of Medical Science, Vol 20, Iss 3, Pp 1016-1021 (2024)
Introduction Atrophic gastritis and intestinal metaplasia are precursor lesions of gastric cancer. The aim of this study was to determine the usefulness of the biomarkers pepsinogen I(PgI), pepsinogen II (PgII), gastrin-17, and H. pylori antibodies i
Externí odkaz:
https://doaj.org/article/a6d7bd37dafd46478e13617e77c73248
Autor:
Seung Joo Kang, Jae Gyu Kim, Hee Seok Moon, Myeong-Cherl Kook, Jong Yeul Lee, Chang Seok Bang, Chung Hyun Tae, Eun Jeong Gong, Su Youn Nam, Hyun Jung Kim
Publikováno v:
The Korean Journal of Helicobacter and Upper Gastrointestinal Research, Vol 24, Iss 2, Pp 143-156 (2024)
Gastritis is a disease characterized by inflammation of the gastric mucosa. It is very common and has various classification systems such as the updated Sydney system. As there is a lot of evidence that Helicobacter pylori infection is associated wit
Externí odkaz:
https://doaj.org/article/dc4c682fef194d45a76be0e58f5485e4
Autor:
Eri Iwata, Mitsushige Sugimoto, Yoshika Akimoto, Mariko Hamada, Ryota Niikura, Naoyoshi Nagata, Kyosuke Yanagisawa, Takao Itoi, Takashi Kawai
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-12 (2024)
Abstract Helicobacter pylori eradication therapy reduces the risk of gastric cancer. However, it is unclear whether the severity of risk factors for gastric cancer such as atrophy and intestinal metaplasia are reduced after eradication in the long te
Externí odkaz:
https://doaj.org/article/451d499eb5854752910369c503a199bd
Rabeprazole suppressed gastric intestinal metaplasia through activation of GPX4-mediated ferroptosis
Autor:
Jing Xie, Xinhua Liang, Fangfang Xie, Canxin Huang, Zijun Lin, Shuping Xie, Fangying Yang, Fengfeng Zheng, Lanlan Geng, Wanfu Xu, Sitang Gong, Li Xiang
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
BackgroundGastric intestinal metaplasia is a common pathological feature in patients with Helicobacter pylori (H. pylori) infection. Rabeprazole was widely used as the first-line regimen for H. pylori infectious treatment. The objective of this study
Externí odkaz:
https://doaj.org/article/ee81512c48054e9c8a32d7b3c6b8ca39
Publikováno v:
JGH Open, Vol 8, Iss 8, Pp n/a-n/a (2024)
Abstract Background and Aim Gastric cancer is a health concern and contributes to cancer‐related deaths. Gastric intestinal metaplasia (GIM) is a premalignant lesion of gastric cancer. Currently, factors associated with GIM regression are under‐i
Externí odkaz:
https://doaj.org/article/cfb95743842f4e8dae3614022fa55834
Autor:
Junya Arai, Hiroaki Fujiwara, Tomonori Aoki, Ryota Niikura, Sozaburo Ihara, Nobumi Suzuki, Yoku Hayakawa, Masato Kasuga, Mitsuhiro Fujishiro
Publikováno v:
Clinics and Practice, Vol 14, Iss 3, Pp 779-788 (2024)
Background: Previous studies demonstrate an association between metabolic factors and Helicobacter pylori-related gastric cancer. However, the association of gastric atrophy or intestinal metaplasia (IM) with these factors remains unknown. Methods: D
Externí odkaz:
https://doaj.org/article/a556d31521bd44ef828ce88f10d02208
Publikováno v:
Current Oncology, Vol 31, Iss 5, Pp 2769-2779 (2024)
Gastric cancer is the fifth most common cancer and the fourth cause of global cancer mortality. The identification of new biomarkers and drug targets is crucial to allow the better prognosis and treatment of patients. The mitotic spindle positioning
Externí odkaz:
https://doaj.org/article/85a86615230443c588841cea967cb047